GlobeImmune's Unattributed VC Round

GlobeImmune raised a round of funding on June 24, 2003.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Unattributed VC Round: